Amendment to June 17, 2005 Warrant between Generex Biotechnology Corporation and Iroquois Capital LP
Contract Categories:
Business Finance
›
Warrant Agreements
Summary
Generex Biotechnology Corporation and Iroquois Capital LP have agreed to amend a previous warrant agreement dated June 17, 2005. Under this amendment, if Iroquois exercises the entire warrant to purchase 609,756 shares at $0.82 per share and submits a Notice of Exercise by October 27, 2005, Generex will allow the exercise to occur earlier than originally permitted. This agreement shortens the waiting period for Iroquois to exercise its rights under the warrant, provided the conditions are met.
EX-4.4 5 v027992_ex4-4.htm
Exhibit 4.4
October 26, 2005
Iroquois Capital LP
641 Lexington Avenue
26th Floor
New York, New York
USA 10022
Attention: Joshua Silverman
Dear Sirs:
| Re: | Generex Biotechnology Corporation - Amendment to Jun 17 05 Warrant |
We make reference to the common stock purchase warrant issued by Generex Biotechnology Corporation (the “Company”) to Iroquois Capital LP (“Iroquois”) on June 17, 2005 pursuant to which the Company granted to Iroquois the entitlement to purchase up to 609,756 shares of the Company’s common stock at $0.82 per share (the “Warrant”).
The Initial Exercise Date (as that term is defined in the Warrant) of the Warrant is expressed therein as the 181st day after the date thereof. The Company hereby confirms that, in consideration of the exercise by Iroquois of not less than 100% of the Warrant and the delivery to the Company of a Notice of Exercise in respect thereof on or before the close of business on October 27, 2005, the Company has agreed to abridge the Initial Exercise Date and to honor the aforementioned Notice of Exercise.
Yours truly,
Generex Biotechnology Corporation
/s/ Mark A. Fletcher
Mark A. Fletcher
Executive Vice-President, General Counsel
maf:hs
